Arcus Biosciences, Inc.
RCUSNYSECIK 1724521HealthcareFiscal year ends Dec 31
All transactions: 4
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-02-18 | Gilead Sciences, Inc.10% owner | Purchase | 1,363,636 | $11.00 | $15.0m | Form 4 |
| 2024-01-29 | Gilead Sciences, Inc.10% owner | Purchase | 15,238,095 | $21.00 | $320.0m | Form 4 |
| 2023-06-28 | Gilead Sciences, Inc.10% owner | Purchase | 1,010,000 | $19.26 | $19.5m | Form 4 |
| 2021-01-31 | Gilead Sciences Inc10% owner | Purchase | 5,650,000 | $39.00 | $220.3m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.